Needle-free COVID-19 vaccine COVI-VAC enters Phase 1 trials

Needle-free COVID-19 vaccine COVI-VAC enters Phase 1 trials

Source: 
Biopharma Reporter
snippet: 

Codagenix’s intranasal COVID-19 vaccine has entered Phase 1 clinical trials: with the first volunteers dosed in the UK.